Gibraltar Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Gibraltar Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.05M	Buy	139,717 +1,090	+0.8%	+$62.6K	1.24%	24
2026 Q1	$8.41M	Buy	138,627 +11,853	+9%	+$691K	1.45%	16
2025 Q4	$6.84M	Sell	126,774 -501	-0.4%	-$24.1K	1.16%	32
2025 Q3	$5.74M	Buy	127,275 +5,811	+5%	+$271K	1.03%	44
2025 Q2	$5.62M	Buy	121,464 +3,109	+3%	+$153K	1.1%	37
2025 Q1	$7.22M	Buy	118,355 +1,487	+1%	+$86.7K	1.56%	20
2024 Q4	$6.61M	Buy	116,868 +1,600	+1%	+$89.4K	2.92%	18
2024 Q3	$5.96M	Buy	115,268 +3,097	+3%	+$145K	2.68%	22
2024 Q2	$4.66M	Buy	112,171 +2,099	+2%	+$93.9K	2.11%	25
2024 Q1	$5.97M	Buy	110,072 +32,691	+42%	+$1.67M	2.78%	21
2023 Q4	$3.97M	Sell	77,381 -15,818	-17%	-$830K	1.69%	25
2023 Q3	$5.41M	Buy	93,199 +2,114	+2%	+$130K	2.4%	22
2023 Q2	$5.82M	Buy	91,085 +1,688	+2%	+$113K	2.58%	20
2023 Q1	$6.2M	Buy	89,397 +1,155	+1%	+$81.5K	2.9%	17
2022 Q4	$6.35M	Buy	88,242 +990	+1%	+$74.6K	3.01%	16
2022 Q3	$6.2M	Sell	87,252 -4,114	-5%	-$298K	3.18%	10
2022 Q2	$7.04M	Sell	91,366 -13,552	-13%	-$1.03M	3.42%	10
2022 Q1	$7.66M	Buy	104,918 +739	+0.7%	+$49.6K	3.19%	12
2021 Q4	$6.5M	Sell	104,179 -3,980	-4%	-$233K	2.94%	16
2021 Q3	$6.4M	Buy	108,159 +3,481	+3%	+$229K	3.25%	15
2021 Q2	$6.98M	Buy	104,678 +6,232	+6%	+$406K	3.49%	11
2021 Q1	$6.2M	Buy	98,446 +14,106	+17%	+$878K	3.19%	12
2020 Q4	$5.23M	Buy	84,340 +872	+1%	+$53.6K	3.12%	10
2020 Q3	$5.03M	Sell	83,468 -5,184	-6%	-$312K	3.51%	6
2020 Q2	$5.21M	Sell	88,652 -995	-1%	-$59.5K	3.83%	7
2020 Q1	$5M	Sell	89,647 -2,030	-2%	-$124K	3.56%	8
2019 Q4	$5.88M	Buy	91,677 +11,156	+14%	+$639K	3.54%	6
2019 Q3	$4.08M	Buy	80,521 +5,145	+7%	+$242K	3.08%	13
2019 Q2	$3.42M	Buy	75,376 +851	+1%	+$39.6K	3.52%	15
2019 Q1	$3.56M	Buy	+74,525	New	+$3.71M	3.57%	10

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Gibraltar Capital Management's BMY Position: Q2 2026 in Review

Gibraltar Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.79% in Q2 2026, buying an estimated $62.6K and bringing the position to 139,717 shares worth $8.05M. The position accounts for 1.24% of the portfolio, ranked #24.

Gibraltar Capital Management first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $8.41M in Q1 2026. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Gibraltar Capital Management held 139,717 shares of Bristol-Myers Squibb worth $8.05M as of Q2 2026.
Gibraltar Capital Management bought 1,090 Bristol-Myers Squibb shares in Q2 2026, an estimated $62.6K.
Bristol-Myers Squibb made up 1.24% of Gibraltar Capital Management's portfolio in Q2 2026, its #24 holding.
Gibraltar Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
Gibraltar Capital Management's Bristol-Myers Squibb position peaked at $8.41M in Q1 2026.
565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gibraltar Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.